WHO ICTRP trial
Evaluation of a rifapentine-containing regimen for intensive phase treatment of…
EUCTR2008-003633-24-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2008-003633-24-ES |
|---|---|
| Public title | Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis Evaluación de una Pauta con Rifapentina para la Fase Intensiva del tratamiento de la Tuberculosis Pulmonar - Study 29 |
| Scientific title | Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis Evaluación de una Pauta con Rifapentina para la Fase Intensiva del tratamiento de la Tuberculosis Pulmonar - Study 29 |
| Primary sponsor | TB Investigation Unit of Barcelona |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | To compare two treatments for Pulmonary Tuberculosis Comparar dos tratamientos para la tuberculosis pulmonar MedDRA version: 9.1 Level: LLT Classification code 10037440 Term: Pulmonary tuberculosis |
| Interventions | Trade Name: Rifadin Product Name: Rifadin Product Code: 0068-0510 Pharmaceutical Form: Capsule, hard INN or Proposed INN: RIFAMPICIN CAS Number: 13292461 Concentration unit: mg milligram(s) Concentration type: up to Concentration number… |
| Registration date | Jul 8, 2008 |
| Target size | 480 |
| Secondary IDs | UITB-Study-29 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: